반응식
[C:1](N)(=O)/[CH:2]=C/C.CN(N)C.C(NC(=O)/C=C(\O[C:21](=[O:39])[C:22]1[CH:27]=[C:26]([S:28]([CH3:30])=[O:29])[C:25]([Cl:31])=[C:24]([NH:32][CH2:33][C:34]2[O:38][CH:37]=[CH:36][CH:35]=2)[CH:23]=1)/C)(C)(C)C.C([NH:43][NH:44][CH2:45][CH3:46])C>>[CH2:1]([N:44]([CH2:45][CH3:46])[NH:43][C:21](=[O:39])[C:22]1[CH:27]=[C:26]([S:28]([CH3:30])=[O:29])[C:25]([Cl:31])=[C:24]([NH:32][CH2:33][C:34]2[O:38][CH:37]=[CH:36][CH:35]=2)[CH:23]=1)[CH3:2]참가 물질
5
실험 절차
By replacing the crotonamide and the unsymmetrical-dimethylhydrazine employed in Example 38 by equimolar quantities of N-tert-butyl-3-(3-furfurylamino-4-chloro-5-methylsulfinylbenzoyloxy)crotonamide and unsymmetrical-diethylhydrazine respectively and then following substantially the same procedure described in Example 38 there is obtained 3-furfurylamino-4-chloro-5-methylsulfinylbenzoic acid 2,2-diethylhydrazide.
출처 및 근거
- ORD 기록
- ord-f0495342c44d4893b56747ec0197063f
- 출처 데이터셋
- uspto-grants-1976_04
- 특허 번호
- US03953476
연결된 노트
불러오는 중…